IMMUNOTHERAPY

Annual Hawaii Cancer Conference

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow

42nd Annual Miami Breast Cancer Conference®

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

Next-Generation Endocrine Therapy for ER+/HER2- Breast Cancer: Addressing Unmet Needs and Keys to Optimization in Clinical Practice

Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions

Empowering Breast Cancer Patients with Non-Opioid Pain Management Innovations

Leveraging Multidisciplinary Teams in an Evolving Treatment Landscape for Early- Stage HR+, HER2- Breast Cancer

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

Community Practice Connection™: Leveraging Multidisciplinary Teams in an Evolving Treatment Landscape for Early- Stage HR+, HER2- Breast Cancer

How We Do It™: Defining HER2 Low on Your Pathology Reports to Make Informed Decisions in Breast Cancer Treatment

Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

24th Annual International Congress on the Future of Breast Cancer® West

24th Annual International Congress on the Future of Breast Cancer® East

Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management

Community Practice Connections™: 23rd Annual International Congress on the Future of Breast Cancer West

23rd Annual School of Breast Oncology

Community Practice Connections™: Navigating Early-Stage HR+/HER2‒- Breast Cancer – Clinical Developments and Innovative Treatments

Community Practice Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2- Breast Cancer

Community Practice Connections™: Case Discussions in TNBC… Navigating the Latest Advances and Impact of Disparities in Care

Medical Crossfire®: Improving Survival in HR-Positive HER2-Negative Metastatic Breast Cancer – Advances in Selective Estrogen Receptor Targeting Therapies

School of Breast Oncology® (SOBO) Slide & Lecture Library